In another study of how pyridine derivatives work as CDK9 inhibitors, Gao et al. synthesized a series of bipyridine derivatives, and among this series, St.41 (Table 7) was the most promising agent with significant activities against various cancer cell lines. Here, CDK9 is linked to cancer.